EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Long‐term safety of ultrathin bioabsorbable‐polymer sirolimus‐eluting stents versus thin durable‐polymer drug‐eluting stents in acute coronary syndrome: A systematic review and meta‐analysis

Fadong Li, Shen Wang, Yue Wang, Can Wei, Yue Wang, Xinyan Liu, Shuaifeng Sun, Wenxin Zhao, Pengrong Guo, Xiaofan Wu

Clinical Cardiology · 2023-12 · 46 (12) · 1465-1473

DOI: 10.1002/clc.24139 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Clinical Cardiology, online erschienen am 03.09.2023. Verfasst von Fadong Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Drug-Eluting Stents, Acute Coronary Syndrome, Coronary Artery Disease, Myocardial Infarction. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundations of China, Capital's Funds for Health Improvement and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Because of the advancement of bioabsorbable polymers and thinner struts, bioabsorbable‐polymer sirolimus‐eluting stents (BP‐SES) with ultrathin struts may be related to superior performance when compared to durable‐polymer drug‐eluting stents (DP‐DES) with thin struts. Nonetheless, the long‐term safety of ultrathin BP‐SES in acute coronary syndrome (ACS) remains unknown.

Methods

We sought to assess the long‐term safety of ultrathin BP‐SES in ACS patients, conducting a thorough meta‐analysis of all relevant trials drawing a comparison between ultrathin BP‐SES and contemporary thin DP‐DES. Target lesion failure (TLF), which includes cardiac death (CD), target‐vessel myocardial infarction (TV‐MI), and clinically driven target lesion revascularization (CD‐TLR) was considered the primary endpoint. Multiple databases comprising Embase, MEDLINE, Cochrane Library, and Pubmed were all thoroughly searched.

Results

There were seven randomized controlled trials included in our study with 7522 randomized patients with ACS (BP‐SES = 3888, DP‐DES = 3634). TLF occurred in 371 (9.5% in BP‐SES) and 393 (10.8% in DP‐DES) patients, respectively, across a 40.7‐month weighted mean follow‐up, with no statistically significant group differences (risk ratio [RR]: 0.87; 95% confidence interval [CI]: 0.73–1.04; p = .12). Furthermore, no significant differences in cardiac death (RR: 0.96; 95% CI: 0.68–1.35; p = .81), TV‐MI (RR: 0.63; 95% CI: 0.36–1.10; p = .10) and CD‐TLR (RR: 0.77; 95% CI: 0.46–1.29; p = .32) were detected between two groups.

Conclusion

During a follow‐up of 40.7 months, ultrathin BP‐SES and thin DP‐DES had a comparable risk of TLF and its individual components (CD, TV‐MI, and CD‐TLR), indicating that ultrathin BP‐SES held at least the same safety and efficiency as thin DP‐DES presented in patients with ACS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Eluting StentsAcute Coronary SyndromeCoronary Artery DiseaseMyocardial InfarctionPercutaneous Coronary InterventionHumansSirolimusEverolimusPolymersAbsorbable ImplantsTreatment OutcomeStentsDeathProsthesis DesignRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

acute coronary syndromebioabsorbable-polymerdrug-eluting stentsultrathin-strut

Substanzen

SirolimusEverolimusPolymers

Autor:innen und Institutionen

  • Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
  • Department of Pathophysiology, Harbin Medical University, Harbin, China.

Förderung

  • National Natural Science Foundations of China
  • Capital's Funds for Health Improvement and Research

Zitieren

APA

Li, F., Wang, S., Wang, Y., Wei, C., Wang, Y., Liu, X., Sun, S., Zhao, W., Guo, P., & Wu, X. (2023). Long‐term safety of ultrathin bioabsorbable‐polymer sirolimus‐eluting stents versus thin durable‐polymer drug‐eluting stents in acute coronary syndrome: A systematic review and meta‐analysis. Clinical Cardiology, 46(12), 1465-1473. https://doi.org/10.1002/clc.24139

Vancouver

Li F, Wang S, Wang Y, Wei C, Wang Y, Liu X, et al. Long‐term safety of ultrathin bioabsorbable‐polymer sirolimus‐eluting stents versus thin durable‐polymer drug‐eluting stents in acute coronary syndrome: A systematic review and meta‐analysis. Clinical Cardiology. 2023;46(12):1465-1473. doi:10.1002/clc.24139

BibTeX
@article{Li2023,
  author = {Li, Fadong and Wang, Shen and Wang, Yue and Wei, Can and Wang, Yue and Liu, Xinyan and Sun, Shuaifeng and Zhao, Wenxin and Guo, Pengrong and Wu, Xiaofan},
  title = {Long‐term safety of ultrathin bioabsorbable‐polymer sirolimus‐eluting stents versus thin durable‐polymer drug‐eluting stents in acute coronary syndrome: A systematic review and meta‐analysis},
  journal = {Clinical Cardiology},
  year = {2023},
  volume = {46},
  number = {12},
  pages = {1465--1473},
  doi = {10.1002/clc.24139}
}
Kostenlos starten →